CareDx CFO has 8,220 shares withheld for taxes

CareDx CFO & COO Keith Kennedy had shares withheld to cover taxes on RSU vesting, and continues to hold over two hundred thousand CDNA shares.

Available on EDGAR 09/15/2026 - 05:12 PM EDT Accepted by SEC EDGAR 09/15/2026 - 05:11 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

CareDx, Inc. (CDNA) reported that its CFO & COO, Keith Kennedy, had 8,220 shares of common stock withheld on September 12, 2026 to pay tax liabilities related to the vesting of restricted stock units. These shares were withheld by the company and not sold in the market. Following this tax-withholding transaction, Kennedy directly holds 211,704 shares of CareDx common stock.

Insider Trade Summary

Tax Withholding: 8,220 shares

Tax Withholding 1 txn

Insider Kennedy Keith

Role CFO & COO

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	8,220	$52.37	$430K

Holdings After Transaction: Common Stock — 211,704 shares (Direct)

Holdings Before and After: Common Stock, 219,924 to 211,704 shares (Direct)

Footnotes (1)

1. F1. These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Key Figures

Shares withheld for tax: 8,220 shares Per-share value for withholding: $52.37 per share Shares held after transaction: 211,704 shares

3 metrics

Shares withheld for tax 8,220 shares Withheld on September 12, 2026 to satisfy tax withholding on RSU vesting

Per-share value for withholding $52.37 per share Value assigned to the 8,220 withheld shares in the tax-withholding transaction

Shares held after transaction 211,704 shares Directly owned by Keith Kennedy following the September 12, 2026 transaction

Key Terms

restricted stock units, tax withholding obligations, Form 4, common stock

4 terms

restricted stock units financial

"in connection with the issuance of shares upon the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"withheld by the Issuer in order to satisfy certain tax withholding obligations"

Form 4 regulatory

"The insider transaction is reported in a Form 4 filed for CareDx, Inc."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

common stock financial

"These shares were withheld in the form of CareDx common stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CareDx (CDNA) report for Keith Kennedy?

CareDx reported that CFO & COO Keith Kennedy had 8,220 shares of common stock withheld on September 12, 2026 to satisfy tax withholding obligations arising from the vesting of restricted stock units.

Was the CareDx (CDNA) insider transaction a market sale?

No. The filing states the 8,220 shares were withheld by the issuer to satisfy tax withholding obligations in connection with RSU vesting, meaning they were not sold in an open-market transaction.

How many CareDx (CDNA) shares does Keith Kennedy hold after this transaction?

After the tax-withholding disposition, CFO & COO Keith Kennedy directly holds 211,704 shares of CareDx common stock, as reported in the Form 4.

At what price were the withheld CareDx (CDNA) shares valued in the Form 4?

The 8,220 shares withheld for tax purposes were valued at $52.37 per share in the Form 4, consistent with a tax-withholding disposition related to restricted stock unit vesting.

Was the CareDx (CDNA) transaction made under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is unchecked, and there is no footnote indicating that the transaction was made under a Rule 10b5-1 or similar pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kennedy Keith

(Last) (First) (Middle)

C/O CAREDX, INC.

8000 MARINA BLVD, 4TH FLOOR

(Street)

BRISBANE CALIFORNIA 94005

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CareDx, Inc. [ CDNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO & COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/12/2026		F		8,220(1)	D	$52.37	211,704	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

	/s/ Jeffrey Adam Novack, Attorney-in-Fact	09/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)